Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-03-10 10:07:06 UTC |
---|
Update Date | 2022-03-07 02:49:11 UTC |
---|
HMDB ID | HMDB0001903 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Calcitriol |
---|
Description | Calcitriol, also known as rocaltrol or 1a,25(OH)2D3, belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. Thus, calcitriol is considered to be a secosteroid lipid molecule. Calcitriol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Calcitriol is a potentially toxic compound. |
---|
Structure | C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol | ChEBI | (1S,3R,5Z,7E)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol | ChEBI | (5Z,7E)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol | ChEBI | 1,25-DHCC | ChEBI | 1-alpha-25-Dihydroxyvitamin D3 | ChEBI | 1alpha,25(OH)2D3 | ChEBI | 1alpha,25-Dihydroxycholecalciferol | ChEBI | 1alpha,25-Dihydroxyvitamin D3 | ChEBI | 5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol | ChEBI | Calcijex | ChEBI | Calcitriolum | ChEBI | Decostriol | ChEBI | Rocaltrol | ChEBI | (1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol | Kegg | (1a,3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol | Generator | (1Α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol | Generator | 1-a-25-Dihydroxyvitamin D3 | Generator | 1-Α-25-dihydroxyvitamin D3 | Generator | 1a,25(OH)2D3 | Generator | 1Α,25(OH)2D3 | Generator | 1a,25-Dihydroxycholecalciferol | Generator | 1Α,25-dihydroxycholecalciferol | Generator | 1a,25-Dihydroxyvitamin D3 | Generator | 1Α,25-dihydroxyvitamin D3 | Generator | (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol | HMDB | 1,25 Dihydroxycholecalciferol | HMDB | 1,25-Dihydroxycholecalciferol | HMDB | 1,25-Dihydroxyvitamin D | HMDB | 1,25-Dihydroxyvitamin D3 | HMDB | 1-alpha,25-Dihydroxyvitamin D3 | HMDB | 1a,25-(OH)2D3 | HMDB | 25-Dihydroxycholecalciferol | HMDB | Dihydroxyvitamin D3 | HMDB | Ro 21-5535 | HMDB | Silkis | HMDB | Soltriol | HMDB | Topitriol | HMDB | Toptriol | HMDB | 1 alpha, 25-Dihydroxy-20-epi-vitamin D3 | HMDB | 1 alpha,25-Dihydroxycholecalciferol | HMDB | 1,25(OH)2-20EPi-D3 | HMDB | Bocatriol | HMDB | Calcitriol alphapharm brand | HMDB | Calcitriol kyramed | HMDB | Calcitriol-nefro | HMDB | Hoffmann-la roche brand OF calcitriol | HMDB | KyraMed, calcitriol | HMDB | Tirocal | HMDB | alpha,25-Dihydroxyvitamin D3, 1 | HMDB | 1,25-Dihydroxy-20-epi-vitamin D3 | HMDB | 20 Epi 1alpha,25 dihydroxycholecaliferol | HMDB | Abbott brand OF calcitriol | HMDB | Calcitriol galderma brand | HMDB | Calcitriol jenapharm brand | HMDB | Calcitriol leo brand | HMDB | Cryopharma brand OF calcitriol | HMDB | Medice brand OF calcitriol | HMDB | Renatriol | HMDB | Roche brand OF calcitriol | HMDB | 1 alpha,25 Dihydroxycholecalciferol | HMDB | 1 alpha,25-Dihydroxyvitamin D3 | HMDB | 20-Epi-1alpha,25-dihydroxycholecaliferol | HMDB | Calcitriol gry brand | HMDB | Calcitriol kyramed brand | HMDB | Calcitriol medice brand | HMDB | Calcitriol nefro | HMDB | Calcitriol renacare brand | HMDB | Calcitriol roche brand | HMDB | D3, 1,25-Dihydroxyvitamin | HMDB | D3, 1,25-Dihydroxy-20-epi-vitamin | HMDB | Galderma brand OF calcitriol | HMDB | Hoffmann la roche brand OF calcitriol | HMDB | KyraMed brand OF calcitriol | HMDB | Leo brand OF calcitriol | HMDB | RenaCare brand OF calcitriol | HMDB | Sitriol | HMDB | 1 alpha, 25 Dihydroxy 20 epi vitamin D3 | HMDB | 1 alpha,25 Dihydroxyvitamin D3 | HMDB | 1,25 Dihydroxyvitamin D3 | HMDB | 1,25 Dihydroxy 20 epi vitamin D3 | HMDB | Alphapharm brand OF calcitriol | HMDB | Calcitriol abbott brand | HMDB | Calcitriol cryopharma brand | HMDB | CalcitriolNefro | HMDB | D3, 1 alpha,25-Dihydroxyvitamin | HMDB | Gry brand OF calcitriol | HMDB | Jenapharm brand OF calcitriol | HMDB | Osteotriol | HMDB | 1a,25-Dihydroxyvitamin D3 / 1a,25-dihydroxycholecalciferol / calcitriol | HMDB | 1Α,25-dihydroxyvitamin D3 / 1α,25-dihydroxycholecalciferol / calcitriol | HMDB | Calcitriol | MeSH |
|
---|
Chemical Formula | C27H44O3 |
---|
Average Molecular Weight | 416.6365 |
---|
Monoisotopic Molecular Weight | 416.329045274 |
---|
IUPAC Name | (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol |
---|
Traditional Name | calcitriol |
---|
CAS Registry Number | 32222-06-3 |
---|
SMILES | C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C |
---|
InChI Identifier | InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1 |
---|
InChI Key | GMRQFYUYWCNGIN-NKMMMXOESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Vitamin D and derivatives |
---|
Direct Parent | Vitamin D and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Triterpenoid
- Tertiary alcohol
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 113 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Calcitriol,1TMS,isomer #1 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C)C[C@@H](O)C[C@@H]1O | 3529.7 | Semi standard non polar | 33892256 | Calcitriol,1TMS,isomer #2 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O[Si](C)(C)C)C[C@@H]1O | 3374.1 | Semi standard non polar | 33892256 | Calcitriol,1TMS,isomer #3 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O[Si](C)(C)C | 3376.5 | Semi standard non polar | 33892256 | Calcitriol,2TMS,isomer #1 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C)C[C@@H](O[Si](C)(C)C)C[C@@H]1O | 3485.3 | Semi standard non polar | 33892256 | Calcitriol,2TMS,isomer #2 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C)C[C@@H](O)C[C@@H]1O[Si](C)(C)C | 3470.9 | Semi standard non polar | 33892256 | Calcitriol,2TMS,isomer #3 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O[Si](C)(C)C)C[C@@H]1O[Si](C)(C)C | 3296.4 | Semi standard non polar | 33892256 | Calcitriol,3TMS,isomer #1 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C)C[C@@H](O[Si](C)(C)C)C[C@@H]1O[Si](C)(C)C | 3400.3 | Semi standard non polar | 33892256 | Calcitriol,1TBDMS,isomer #1 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C(C)(C)C)C[C@@H](O)C[C@@H]1O | 3756.9 | Semi standard non polar | 33892256 | Calcitriol,1TBDMS,isomer #2 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O | 3584.0 | Semi standard non polar | 33892256 | Calcitriol,1TBDMS,isomer #3 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O[Si](C)(C)C(C)(C)C | 3573.8 | Semi standard non polar | 33892256 | Calcitriol,2TBDMS,isomer #1 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C(C)(C)C)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O | 3934.9 | Semi standard non polar | 33892256 | Calcitriol,2TBDMS,isomer #2 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C(C)(C)C)C[C@@H](O)C[C@@H]1O[Si](C)(C)C(C)(C)C | 3892.9 | Semi standard non polar | 33892256 | Calcitriol,2TBDMS,isomer #3 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O[Si](C)(C)C(C)(C)C | 3694.6 | Semi standard non polar | 33892256 | Calcitriol,3TBDMS,isomer #1 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[Si](C)(C)C(C)(C)C)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O[Si](C)(C)C(C)(C)C | 4050.3 | Semi standard non polar | 33892256 |
|
---|
General References | - Mason RS, Lissner D, Grunstein HS, Posen S: A simplified assay for dihydroxylated vitamin D metabolites in human serum: application to hyper- and hypovitaminosis D. Clin Chem. 1980 Mar;26(3):444-50. [PubMed:6892691 ]
- Shepard RM, Horst RL, Hamstra AJ, DeLuca HF: Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55-69. [PubMed:227368 ]
- Mason RS, Frankel T, Chan YL, Lissner D, Posen S: Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med. 1984 Jan;100(1):59-61. [PubMed:6546329 ]
- Mallette LE: Case report: hypoparathyroidism with menses-associated hypocalcemia. Am J Med Sci. 1992 Jul;304(1):32-7. [PubMed:1642251 ]
- Ott SM, Chesnut CH 3rd: Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med. 1989 Feb 15;110(4):267-74. [PubMed:2913914 ]
- Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Juppner H, Wolf M: Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int. 2006 Oct;70(8):1486-94. Epub 2006 Aug 30. [PubMed:16941023 ]
- Josephson MA, Schumm LP, Chiu MY, Marshall C, Thistlethwaite JR, Sprague SM: Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004 Oct 27;78(8):1233-6. [PubMed:15502727 ]
- Gallagher JC, Goldgar D: Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med. 1990 Nov 1;113(9):649-55. [PubMed:2221645 ]
- Lehmann B, Sauter W, Knuschke P, Dressler S, Meurer M: Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res. 2003 Apr;295(1):24-8. Epub 2003 Mar 11. [PubMed:12709817 ]
- Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D: Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 2005 Sep 1;65(17):7917-25. [PubMed:16140963 ]
- Kalkwarf HJ, Specker BL, Heubi JE, Vieira NE, Yergey AL: Intestinal calcium absorption of women during lactation and after weaning. Am J Clin Nutr. 1996 Apr;63(4):526-31. [PubMed:8599316 ]
|
---|